These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37931803)

  • 1. Inflammation Is a Histological Characteristic of Skeletal Muscle in Chronic Limb Threatening Ischemia.
    Ferreira J; Afonso J; Longatto-Filho A; Roque S; Carneiro A; Vila I; Silva C; Cunha C; Mesquita A; Cotter J; Correia-Neves M; Mansilha A; Cunha P
    Ann Vasc Surg; 2024 Feb; 99():10-18. PubMed ID: 37931803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and Loss of Skeletal Muscle Mass in Chronic Limb Threatening Ischemia.
    Ferreira J; Carneiro A; Vila I; Silva C; Cunha C; Longatto-Filho A; Mesquita A; Cotter J; Mansilha A; Correia-Neves M; Cunha P
    Ann Vasc Surg; 2023 Jan; 88():164-173. PubMed ID: 35926785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversion of the Inflammatory Markers in Patients With Chronic Limb-Threatening Ischemia.
    Ferreira J; Roque S; Lima Carneiro A; Longatto-Filho A; Vila I; Cunha C; Silva C; Mesquita A; Cotter J; Correia-Neves M; Mansilha A; Cunha PG
    J Am Heart Assoc; 2024 Apr; 13(8):e031922. PubMed ID: 38606780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinterventions in Patients with Claudication and Chronic Limb Threatening Ischemia.
    Mohamedali A; Kiwan G; Kim T; Zhang Y; Zhuo H; Tonnessen B; Dardik A; Chaar CIO
    Ann Vasc Surg; 2022 Feb; 79():56-64. PubMed ID: 34656724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk Factor Analysis and Long-Term Outcomes in Patients with Endovascular Revascularization for Intermittent Claudication or Chronic Limb-Threatening Ischemia.
    Fung V; Chan YC; Cheung GC; Cheng SW
    Ann Vasc Surg; 2023 Feb; 89():261-268. PubMed ID: 36162626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short and long-term outcome after common femoral artery hybrid procedure in patients with intermittent claudication and chronic limb threatening ischemia.
    Woronowicz-Kmiec S; Betz T; Töpel I; Bröckner S; Steinbauer M; Uhl C
    Vasa; 2021 Sep; 50(5):363-371. PubMed ID: 33973817
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences In Anthropometric Measures Between Critical Limb Threatening Ischaemia And Intermittent Claudication In Patients Undergoing Aorto Bifemoral Bypass.
    Ferreira J; Campos J; Braga S; Sousa P; Simões J; Carrilho C; Canedo A; Mesquita A
    Rev Port Cir Cardiotorac Vasc; 2020; 27(2):111-116. PubMed ID: 32707618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Reinterventions for Claudication are Associated with Progression to Chronic Limb-Threatening Ischemia.
    Kim TI; Kiwan G; Mohamedali A; Zhang Y; Dardik A; Guzman RJ; Ochoa Chaar CI
    Ann Vasc Surg; 2021 Apr; 72():166-174. PubMed ID: 33227462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-Year Outcomes of Orbital Atherectomy for the Endovascular Treatment of Infrainguinal Claudication or Chronic Limb-Threatening Ischemia.
    Giannopoulos S; Secemsky EA; Mustapha JA; Adams G; Beasley RE; Pliagas G; Armstrong EJ
    J Endovasc Ther; 2020 Oct; 27(5):714-725. PubMed ID: 32618486
    [No Abstract]   [Full Text] [Related]  

  • 10. Rates of Intervention for Claudication versus Chronic Limb-Threatening Ischemia in Canada and United States.
    Li B; Rizkallah P; Eisenberg N; Forbes TL; Roche-Nagle G
    Ann Vasc Surg; 2022 May; 82():131-143. PubMed ID: 34902467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of palliative care consultation into the management of patients with chronic limb-threatening ischemia.
    Cattermole TC; Schimmel ML; Carpenter RL; Callas PW; Gramling R; Bertges DJ; Ferranti KM
    J Vasc Surg; 2023 Aug; 78(2):454-463. PubMed ID: 37088444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative outcomes of infrainguinal bypass surgery in patients with and without prior revascularization.
    Bodewes TCF; Ultee KHJ; Soden PA; Zettervall SL; Shean KE; Jones DW; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 May; 65(5):1354-1365.e2. PubMed ID: 28190717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of a Machine Learning-Based Risk Stratification Scheme for Chronic Limb-Threatening Ischemia.
    Chung J; Freeman NLB; Kosorok MR; Marston WA; Conte MS; McGinigle KL
    JAMA Netw Open; 2022 Mar; 5(3):e223424. PubMed ID: 35315918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in major limb outcomes by indication for lower extremity endovascular revascularization in patients receiving hemodialysis.
    Iwai T; Yamaguchi T; Ueshima D; Tobita K; Mizuno A; Fujimoto Y; Miyazaki R; Shimura T; Goto R; Murata N; Anzai H; Higashitani M
    Heart Vessels; 2023 Apr; 38(4):488-496. PubMed ID: 36322238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Skeletal muscle regeneration failure in ischemic-damaged limbs is associated with pro-inflammatory macrophages and premature differentiation of satellite cells.
    Southerland KW; Xu Y; Peters DT; Lin X; Wei X; Xiang Y; Fei K; Olivere LA; Morowitz JM; Otto J; Dai Q; Kontos CD; Diao Y
    Genome Med; 2023 Nov; 15(1):95. PubMed ID: 37950327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of chronic limb-threatening ischemia due to inflammatory nonatherosclerotic versus atherosclerotic etiologies undergoing revascularization.
    Iida O; Takahara M; Kodama A; Yamaoka T; Soga Y; Mano T
    Vasc Med; 2023 Aug; 28(4):299-307. PubMed ID: 37093717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe inframalleolar disease is an independent predictor of adverse limb outcomes after endovascular revascularization in chronic limb-threatening ischemia.
    Naiem AA; Bergeron A; MacKenzie KS; Obrand DI; Steinmetz OK; Bayne JP; Gill HL; Girsowicz E
    J Vasc Surg; 2023 Mar; 77(3):858-863. PubMed ID: 36332807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient selection and perioperative outcomes of bypass and endovascular intervention as first revascularization strategy for infrainguinal arterial disease.
    Bodewes TCF; Darling JD; Deery SE; O'Donnell TFX; Pothof AB; Shean KE; Moll FL; Schermerhorn ML
    J Vasc Surg; 2018 Jan; 67(1):206-216.e2. PubMed ID: 28844467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated estimates for the burden of chronic limb-threatening ischemia in the Medicare population.
    Kwong M; Rajasekar G; Utter GH; Nuño M; Mell MW
    J Vasc Surg; 2023 Jun; 77(6):1760-1775. PubMed ID: 36758910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of aorto(bi)femoral bypass in treatment of patients with critical limb threatening ischemia.
    Betz T; Toepel I; Pfister K; Steinbauer M; Uhl C
    Surgeon; 2021 Apr; 19(2):103-110. PubMed ID: 32507455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.